| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |